Search - tctmd.com

Displaying 181 - 200 of 872

Sort: Relevancy | Date

Presentation ECHO 2016

Hemodynamics II Echo Quantification of Valvular Regurgitation (Vena Contracta, Effective Regurgitant Orifice Area, and Regurgitant Volume, Regurgitant Fraction)

Presenter: Linda D. Gillam

March 21, 2016

News Industry News

BioStable Science & Engineering Announces CE Mark Approval for the HAART 300 Aortic Annuloplasty Device

March 07, 2016

News Industry News

Edwards SAPIEN XT Valve Receives FDA Approval For Pulmonic Procedures

March 01, 2016

News Conference News CRT 2016

Will the MitraClip and Other Gadgets Make Headway in Functional MR?

Shelley Wood

February 25, 2016

News Daily News

Transcatheter Aortic Valve Outcomes Better in Women Than Men at 12 Months

Shelley Wood

February 23, 2016

News Industry News

Mitralign Percutaneous Annuloplasty System Earns CE Mark Approval for Functional Mitral Regurgitation

February 21, 2016

News Conference News CRT 2016

Early Results for Transcatheter Mitral Valve Replacement Reveal Complications and Challenges for the Long Road Ahead

Shelley Wood

February 21, 2016

News Daily News

Anthracycline-Based Chemotherapy Linked to Valve Disease, Even in Absence of Radiation

L.A. McKeown

February 16, 2016

Presentation JIM 2016

Mitralign: Transcatheter Repair for Functional Mitral Regurgitation

Presenter: Azeem Latib

February 11, 2016

Presentation Scripps 2016

The “Forgotten Valve”: Current and Emerging Options for Catheter Based Treatment of Tricuspid Regurgitation

Presenter: Rebecca T. Hahn

February 03, 2016

News Daily News

Early Invasive Intervention Trumps Delayed Approach in NSTEMI Patients

Michael O'Riordan

January 20, 2016

News Industry News

Neovasc Receives FDA Approval to add 40mm Valve Size to the TIARA-I Clinical Trial

January 10, 2016

News Daily News

Many Childhood Cancer Survivors Have Silent Cardiac Conditions

Yael L. Maxwell

January 06, 2016

News Daily News

Sapien a ‘Viable and Durable’ Option in Transcatheter Pulmonary Valve Replacement

Michael O'Riordan

December 27, 2015

Presentation

Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation (MR):5-Year results of EVEREST II

Presenter: Ted Feldman

December 21, 2015

News Daily News

Percutaneous Mitral Repair Looks Durable, Safe, in 5-Year Final Results from EVEREST II

L.A. McKeown

December 21, 2015

News Daily News

La Reparación Mitral Percutánea parece Duradera y Segura en los Resultados a 5 Años del EVEREST II

L.A. McKeown

December 21, 2015

News Daily News

EVEREST II 5 年的最终结果显示经皮二尖瓣修补似乎持久、安全

L.A. McKeown

December 21, 2015

News Industry News

BioVentrix Announces 30th Clinical Case Milestone for Revivent-TC™ Technology

December 13, 2015

News Daily News

La 1ª Reparación Transcatéter en Humanos de la Válvula Tricúspide es Viable pero Plantea Interrogantes

Michael O'Riordan

December 06, 2015

Advertisement

Hemodynamics II Echo Quantification of Valvular Regurgitation (Vena Contracta, Effective Regurgitant Orifice Area, and Regurgitant Volume, Regurgitant Fraction)

BioStable Science & Engineering Announces CE Mark Approval for the HAART 300 Aortic Annuloplasty Device

Edwards SAPIEN XT Valve Receives FDA Approval For Pulmonic Procedures

Will the MitraClip and Other Gadgets Make Headway in Functional MR?

Transcatheter Aortic Valve Outcomes Better in Women Than Men at 12 Months

Mitralign Percutaneous Annuloplasty System Earns CE Mark Approval for Functional Mitral Regurgitation

Early Results for Transcatheter Mitral Valve Replacement Reveal Complications and Challenges for the Long Road Ahead

Anthracycline-Based Chemotherapy Linked to Valve Disease, Even in Absence of Radiation

Mitralign: Transcatheter Repair for Functional Mitral Regurgitation

The “Forgotten Valve”: Current and Emerging Options for Catheter Based Treatment of Tricuspid Regurgitation

Early Invasive Intervention Trumps Delayed Approach in NSTEMI Patients

Neovasc Receives FDA Approval to add 40mm Valve Size to the TIARA-I Clinical Trial

Many Childhood Cancer Survivors Have Silent Cardiac Conditions

Sapien a ‘Viable and Durable’ Option in Transcatheter Pulmonary Valve Replacement

Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation (MR):5-Year results of EVEREST II

Percutaneous Mitral Repair Looks Durable, Safe, in 5-Year Final Results from EVEREST II

La Reparación Mitral Percutánea parece Duradera y Segura en los Resultados a 5 Años del EVEREST II

EVEREST II 5 年的最终结果显示经皮二尖瓣修补似乎持久、安全

BioVentrix Announces 30th Clinical Case Milestone for Revivent-TC™ Technology

La 1ª Reparación Transcatéter en Humanos de la Válvula Tricúspide es Viable pero Plantea Interrogantes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content